Isomorphic Labs raises $5 billion to take AI-designed drugs towards clinical trials
The latest funding round comes six months after the company secured $2.1 billion, with Alphabet and existing investors participating again
Quartz Alphabet's Isomorphic Labs raised $5 billion in Series C funding for AI drug design
Greenoaks and Sequoia Capital co-led the round as the Alphabet unit works to move its first drug programs toward clinical trials
Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: G/O Media



















